Economic Moat We believe Icon's global CRO business warrants a narrow moat due to its significant late-stage trial exposure and intangible assets of proprietary data and technology, expertise, and ...
Icon issued solid guidance for fiscal-year 2023 broadly in line with our expectations. We expect the firm will achieve 2023 adjusted earnings per share of $12.75 and revenue of $8.14 billion, ...